Feasibility of a home-designed respiratory rehabilitation program for chronic obstructive pulmonary disease

Nidhal Belloumi,Chaima Habouria,Imen Bachouch,Meriem Mersni,Fatma Chermiti,Soraya Fenniche
DOI: https://doi.org/10.1017/s1463423623000324
2024-02-01
Primary Health Care Research & Development
Abstract:Background: According to international guidelines, respiratory rehabilitation (RR) for patients with chronic obstructive pulmonary disease (COPD) is a cornerstone of standard non-pharmacological treatment. Aims: To evaluate feasibility of a home-designed RR program and analyze its medium-term impact on respiratory parameters and quality of life. Methods: This was a prospective study involving 74 COPD patients enrolled in January 2019 and put on inhaled bronchodilator treatment associated with RR at home following a written protocol, for 16 weeks. The comparative statistical analysis highlights the difference before and after RR in terms of clinical and functional respiratory parameters as well as in terms of quality of life (assessed on the short form 36 (SF-36) questionnaire). The comparison involves RR-adherent patients versus non-adherent patients. Results: Mean age was 66.7 ± 8.3 years with a median of 67 years. All patients were smokers, out of which 42 patients (57%) did not quit yet. Forty-one percent of patients were frequent exacerbators. The average COPD assessment test (CAT) score in our patients was 23. The average 6-minutes walk distance (MWD) was 304 m. The BODE index in our patients was 4.11 on average. The RR program was followed by 36 patients (48%). Thirty patients (40%) applied it at least twice a week. RR-adherent patients had an average CAT score decreasing from 23 to 14.5 (P = 0.011). Their average 6-MWD was 444.6 m by the end of the study, which would be 64.2% of the calculated theoretical value. The average FEV1 increase after RR was 283 mL. The majority (69%) of RR-adherent patients were ranked as quartile 1; BODE index ≤2. The average scores of physical, psycho-social, and general dimensions assessed on the SF-36 questionnaire improved in RR-adherent patients. Conclusions: RR is a key non-pharmacological treatment for COPD. Its interest originates from its multidisciplinary nature, hence its effectiveness in several respiratory parameters. Our study reflects the feasibility of home-designed protocols in the absence of contraindications. We highlight also the positive impact on quality of life after RR at home.
primary health care
What problem does this paper attempt to address?
The paper attempts to address the feasibility and mid-term impact of a home-designed Respiratory Rehabilitation (RR) program for patients with Chronic Obstructive Pulmonary Disease (COPD). Specifically, the study aims to: 1. **Assess Feasibility**: Evaluate the feasibility of this home-designed respiratory rehabilitation program in COPD patients. 2. **Analyze Impact**: Analyze the mid-term impact of the program on respiratory parameters and quality of life. ### Research Background According to international guidelines, respiratory rehabilitation (RR) is one of the standard non-pharmacological treatments for COPD. However, many patients are unable to adhere to these programs due to the lack of specialized rehabilitation centers or personal reasons. Therefore, a home-designed respiratory rehabilitation program has been proposed as an alternative to overcome these barriers. ### Research Objectives - **Primary Objective**: Compare respiratory function parameters between rehabilitation-adherent patients (RA) and non-adherent patients (RNA) to evaluate the actual effect of this non-pharmacological treatment. - **Secondary Objective**: Assess the adherence of a group of COPD patients to a simplified home-designed respiratory rehabilitation program. ### Research Methods - **Study Type**: Prospective open-label study, lasting for 1 year, from January 2019 to December 2019. - **Study Subjects**: 74 COPD patients were included, who, while receiving inhaled long-acting bronchodilator treatment, underwent 16 weeks of home respiratory rehabilitation training according to a written protocol. - **Assessment Indicators**: Included clinical and functional respiratory parameters (such as CAT score, 6-minute walk distance, FEV1, etc.) and quality of life (assessed by the SF-36 questionnaire). ### Main Results - **Adherence**: 36 patients (48%) followed the rehabilitation program, with 30 patients (40%) training at least twice a week. - **Improvement in Respiratory Parameters**: The average CAT score of adherent patients decreased from 23 to 14.5 (P=0.011), the 6-minute walk distance increased from 304 meters to 444.6 meters, and FEV1 increased by 283 milliliters. - **Improvement in Quality of Life**: The average scores in various dimensions of the SF-36 questionnaire for adherent patients improved, particularly in physical function and psychosocial aspects. ### Conclusion - Respiratory rehabilitation is a key non-pharmacological treatment for COPD management, and its multidisciplinary nature shows effectiveness in multiple respiratory parameters. - This study reflects the feasibility of a home-designed rehabilitation program in the absence of contraindications and highlights the positive impact of home respiratory rehabilitation on improving quality of life.